On Wednesday, the FDA announced that the Johnson and Johnson coronavirus vaccine was safe, more effective on serious cases of Covid-19 than on more moderate cases, and totally protective against hospitalizations and death.  Today, the independent group of infectious disease professionals that advises the FDA on whether a vaccine should receive a thumb’s up or
0 Comments
An FDA advisory panel lent their support today to a rapid clearance for Janssen/Johnson & Johnson’s COVID-19 vaccine. The Food and Drug Administration (FDA) is expected to quickly provide an emergency use authorization (EUA) for the vaccine following the recommendation by the panel. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 22-0 on
0 Comments
by Sarah Kwon This story also ran on NBC News. For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19
0 Comments
In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. “I said ‘Oh, my God!’ ” she recalled. “Super loud. My kids jumped up. My husband looked over. He said, ‘What’s wrong, what’s wrong, is everything OK?’ I was like, ‘No, no, it’s
0 Comments
Preterm labor comprises 12.7% of all pregnancies. Although the overall rate of pregnancy is decreasing, the occurrence of premature birth due to preterm labor in south korea has been increasing over the past 7 years. Not only is preterm birth accountable for about a half of all neonatal mortality cases, the neurological deficits in surviving
0 Comments
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45 CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) —  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Amondys
0 Comments
People wait in line for coronavirus disease (COVID-19) vaccinations at Martin Luther King Jr. Community Hospital in Willowbrook, Los Angeles, California, February 25, 2021. Lucy Nicholson The U.S. is “nowhere close” to achieving herd immunity from Covid, and more transmissible variants mean even more people will need to get vaccinated to reach it, a CDC
0 Comments
While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery. Now, research from the Children’s Medical Center Research Institute at UT Southwestern (CRI) has identified the cells responsible for liver maintenance and regeneration while also pinpointing where they
0 Comments
Satjit Bhusri, MD, is worried about heart health, his own, and yours. A long-time New York City cardiologist, he is now treating the aftereffects of Covid-19. “What’s unusual about COVID…is that it is extremely inflammatory. That means the body attacks [the virus], and [the immune system] kind of goes overboard,” he said. What is unnerving
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two research teams have identified a new coronavirus variant in New York City and across the Northeast that could evade natural immune responses and some monoclonal antibody treatments, according to CNN. The variant, called B.1.526, has appeared in diverse neighborhoods in
0 Comments
22 February 2021 — AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer. This decision was made in consultation with the Food and Drug Administration (FDA). In May 2017, Imfinzi was granted accelerated approval in the US based on promising
0 Comments
maralixibat Treatment for Cholestatic Pruritus in Patients with Alagille Syndrome Mirum Pharmaceuticals Announces Completion of Rolling NDA Submission for Maralixibat in Alagille Syndrome FOSTER CITY, Calif.–(BUSINESS WIRE)–Feb. 1, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced it has completed submission of its rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for maralixibat for the
0 Comments
Pfizer board member Dr. Scott Gottlieb told CNBC on Thursday that the company is researching two distinct methods to try providing vaccine protection against new coronavirus variants. In an interview on “Squawk Box,” Gottlieb said the first approach is focused on whether a booster shot using the current formulation of the two-dose vaccine would provide additional defense.
0 Comments
The current coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been observed to be less serious in infants and children. However, this age group is also subject to certain complications following infection. A new preprint on the medRxiv* server describes the findings of an observational study of children
0 Comments
Amid national outcry for racial justice last summer, neuroscience graduate student Angeline Dukes yearned for a sense of community among Black scholars in her field. Following the murder of George Floyd and subsequent Black Lives Matter protests, Black scientists from other disciplines — including astronomy, botany, geology, marine science, and ornithology — created online movements
0 Comments
In December, the Supreme Court reversed a lower court ruling that had allowed abortion medications to be sent by mail. Since then, women looking to terminate a pregnancy with the combination medications packet containing mifepristone and misoprostol now must go, in person, to a medical provider. But this in-person requirement is not necessary in many
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. HOUSTON (AP) — A giant vaccination center is opening in Houston to administer 126,000 coronavirus doses in the next three weeks. Nevada health officials are working overtime to distribute delayed shots. And Rhode Island is rescheduling appointments after a vaccine shipment
0 Comments
Sponsored Content by PittconFeb 24 2021 Thought LeadersProf. Parastoo HashemiAssistant Professor of ChemistryDepartment of Chemistry and BiochemistryUniversity of South Carolina In this interview, News-Medical Life Sciences talks to Parry Hashemi about the research on in vivo probes for detecting inflammation markers in humans and animals that she will present at Pittcon. What are some traditional
0 Comments
Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients ROCKVILLE, Md., Feb. 08, 2021 (GLOBE NEWSWIRE) – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced it has resubmitted its
0 Comments